新薬紹介総説 新規C型肝炎治療薬エルバスビル(エレルサ錠50mg)・グラゾプレビル(グラジナ錠50mg)の薬理作用と臨床試験成績
Digital data available（Japan Link Center）
Begin reading now
CiNii Research
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
CiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Author/Editor
- 木下 潔岩佐 隆史Ernest Asante-Appiah中村 圭介
- Author Heading
- Alternative Title
- Preclinical and clinical properties of elbasvir (ERELSA Tablets 50 mg) and Grazoprevir (GRAZYNA Tablets 50 mg), novel therapeutic agents for hepatitis C
- Periodical title
- 日本薬理学雑誌 = Folia pharmacologica Japonica : くすりとからだ : ファーマコロジカ
- No. or year of volume/issue
- 150(1)=796:2017.7
- Volume
- 150
- Issue
- 1
- Sequential issue number
- 796